大麻使用障碍的流行:对人口调查的元分析
Cassandra L Boness1, Rory A Pfund2, Samuel Acuff3
1Center on Alcohol, Substance use, and Addictions (CASAA), University of New Mexico, Albuquerque, New Mexico.
Journal of studies on alcohol and drugs
|June 26, 2024
概括
由于方法上的差异,大麻使用和大麻使用障碍流行率的估计有很大差异. 这一元分析强调了对泛化的担忧,并提出了改善未来大麻流行病学研究的建议.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 药物使用研究研究 药物使用研究
背景情况:
- 流行病学调查对于估计大麻使用和大麻使用障碍的人口患病率至关重要.
- 现有调查中的差异性估计引发了对可靠性和理解趋势的担忧,例如政策影响.
- 进行了一项元分析,以确定患病率估计中的不可靠性来源.
研究的目的:
- 确定大麻使用和大麻使用障碍的流行率估计中不可靠的潜在来源.
- 综合现有的流行数据并评估异质性.
- 测试流行率估计的潜在调节者,包括国家,年份和方法.
主要方法:
- 进行了系统的搜索,以确定全国代表性的大麻使用障碍的患病率估计.
- 使用元分析来综合流行数据,评估异质性,并检查影响因素.
- 包括39份手稿/报告,其中有259个独特的流行率估计 (1980-2013,N=973,281).
主要成果:
- 去年大麻使用率为12.83%,终身使用率为38.31%.
- 过去一年大麻使用障碍的患病率为2.59%;终身患病率为6.77%.
- 观察到显著的异质性,部分取决于国家,数据收集年份和方法特征.
结论:
- 与方法因素相关的流行率估计中的显著异质性,引发了对概括性的担忧.
- 方法的变化会影响大麻使用的可靠性和大麻使用障碍的流行数据.
- 提供了建议,以提高未来流行率估计的有效性和可靠性.
相关概念视频
Substance Use Disorders Affecting Sleep
164
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
164
Diagnostic and Statistical Manual of Mental Disorders (DSM)
54
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
54
Drug Abuse and Addiction: Pharmacological Phenomena
463
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
463
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
180
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
180
CNS Depressants: Alcohol and Nicotine
201
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
201
Attention-Deficit/Hyperactivity Disorder
54
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
54


